Cite
HARVARD Citation
de Boer, S. et al. (2018). Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. Annals of oncology. pp. 424-430. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
de Boer, S. et al. (2018). Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. Annals of oncology. pp. 424-430. [Online].